DUBLIN--(BUSINESS WIRE)--
Research and Markets (http://www.researchandmarkets.com/research/0451a3/carbohydratebased)
has announced the addition of John Wiley and Sons Ltd's new report "Carbohydrate-Based
Vaccines and Immunotherapies" to their offering.
The fundamental science and the latest developments in
carbohydrate-based vaccines.
The relatively new field of glycoimmunology has emerged from the
marriage of glycobiology and immunology, in recognition of the important
role carbohydrates play as antigenic determinants. Carbohydrate-Based
Vaccines and Immunotherapies comprehensively reviews the state of
this exciting field, offering a single source for both the fundamental
science and the latest developments.
With contributions by leading experts, this resource covers the design,
synthesis, evaluation, and applications of various carbohydrate-based
vaccines, including polysaccharides, neoglycoproteins, and
neoglycolipids. The text approaches vaccine design from a chemical and
molecular focus, staying in line with current advances.
Key topics covered by Carbohydrate-Based
Vaccines and Immunotherapies include:
-
Recent developments towards clinically useful vaccines against
bacteria, viruses, parasites, and fungi
-
Using adjuvants to improve immunogenicity and/or immunological
properties of vaccines
-
Choosing and designing proper adjuvants for specific targets
-
Abnormal carbohydrates expressed by tumors
-
Carbohydrate-based therapeutic cancer vaccines or cancer immunotherapy
-
Clinical trials results for synthetic cancer vaccines
-
Glycoengineering of cell surface carborhydrates and its anticancer
applications
-
Using cell surface carbohydrates for disease diagnosis
A single, convenient source of state-of-the-art information from leading
authorities in the field, Carbohydrate-Based
Vaccines and Immunotherapies is an essential reference for organic
chemists and biochemists, academic researchers, and other students and
professionals involved in vaccine design.
Key Topics Covered:
Chapter 1: Glycobiology and Immunology (Udayanath Aich and Kevin J.
Yarema).
Chapter 2: Preparation of Glycoconjugate Vaccines (Wei Zou and Harold J.
Jennings).
Chapter 3: Adjuvants for Protein- and Carbohydrate-Based Vaccines (Bruno
Guy).
Chapter 4: Carbohydrate-Based Antibacterial Vaccines (Robert A. Pon and
Harold J. Jennings).
Chapter 5: Carbohydrate-Based Antiviral Vaccines (Benjamin M. Swarts and
Zhongwu Guo).
Chapter 6: Carbohydrate-Based Antiparasitic Vaccines (Faustin Kamena,
Xinyu Liu and Peter H. Seeberger).
Chapter 7: Carbohydrate-Based Antifungal Vaccines (Magdia De Jesus,
Liise-anne Pirofski and Arturo Casadevall).
Chapter 8: Cancer-Associated and Related Glycosphingolipid Antigens
(Steve Levery).
Chapter 9: Synthetic Carbohydrate-Based Anticancer Vaccines (Therese
Buskas, Pamela Thompson, and Geert-Jan Boons).
Chapter 10: Glycoengineering of Cell Surface Sialic Acid and Its
Application to Cancer Immunotherapy (Zhongwu Guo).
Chapter 11: Therapeutic Cancer Vaccines: Clinical Trials and
Applications (Hans H. Wandall and Mads A. Tarp).
Chapter 12: Carbohydrates as Unique Structures for Disease Diagnosis
(Kate Rittenhouse-Olson).
For more information visit http://www.researchandmarkets.com/research/0451a3/carbohydratebased
